VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
35 hedge funds and large institutions have $238M invested in Verona Pharma in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.4% more ownership
Funds ownership: 8.22% → 8.62% (+0.4%)
18% less call options, than puts
Call options by funds: $85K | Put options by funds: $104K
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
35
Holding in Top 10
3
Calls
$85K
Puts
$104K
Top Buyers
| 1 | +$8.72M | |
| 2 | +$5.66M | |
| 3 | +$1.94M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$235K |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
+$187K |
Top Sellers
| 1 | -$6.93M | |
| 2 | -$1.86M | |
| 3 | -$219K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$77K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$47.5K |